Nanalysis Scientific Corp. (TSXV:NSCI)

Market Cap	28.31M
Revenue (ttm)	44.93M
Net Income (ttm)	-12.40M
Shares Out	113.22M
EPS (ttm)	-0.11
PE Ratio	n/a
Forward PE	31.66
Dividend	n/a
Ex-Dividend Date	n/a

Volume	191,800
Average Volume	79,802
Open	0.2500
Previous Close	0.2500
Day's Range	0.2500 - 0.2550
52-Week Range	0.2450 - 0.4700
Beta	0.30
RSI	42.29
Earnings Date	Aug 25, 2025

About Nanalysis Scientific

Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60-NMR platform; 100-NMR platform; 60-TEACH Platform; QUAD NMR Console; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides softwa...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• CEO: Sean Krakiwsky
• Employees: 249
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: NSCI

Financial Performance

In 2024, Nanalysis Scientific's revenue was 45.50 million, an increase of 59.82% compared to the previous year's 28.47 million. Losses were -13.61 million, -15.95% less than in 2023.